Tanaka, Shiro http://orcid.org/0000-0001-6817-5235
Mori, Satoshi
Hagino, Hiroshi
Sugimoto, Toshitsugu
Funding for this research was provided by:
Public Health Research Foundation (N/A)
Asahi Kasei Pharma Corporation (N/A)
Article History
Received: 26 August 2019
Accepted: 10 December 2019
First Online: 1 January 2020
Compliance with ethical standards
:
: ST has received lecture fees from Astra-Zeneca, Taiho, and Ono. He has received consultation fees from DeNA Life Science and CanBus. He has received outsourcing fees from Satt and Asahi Kasei Pharma. HH has received lecture and consultancy fees from Asahi Kasei Pharma Corp., Astellas Pharma Inc., MSD Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Pfizer Co., Ltd., Mitsubishi Tanabe Pharma Corp., Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Pfizer Inc., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. TS has received research grants from Astellas Pharma, Eisai, Daiichi-Sankyo, Chugai Pharmaceutical and Eli Lilly Japan as well as consulting and/or lecture fees from Asahi Kasei Pharma, MSD and Daiichi-Sankyo. SM has no conflicts of interest to disclose.